Valeur20202021202220232024TTMFlux de trésorerie liés aux activités d'investissement-7.26 M11.78 M9.7 M10.58 M8.03 M11.32 MFlux de trésorerie liés aux activités de financement61.4 M7.5 M8.02 M8.84 M9.53 M—Flux de trésorerie disponible-30.91 M-36.5 M-22.86 M-18.02 M-19.83 M-21.69 M
Pluri Inc. - Common Stock
Pluri Inc., formerly Pluristem Therapeutics, is an Israeli company engaged in the development of human placental adherent stromal cells for commercial use in disease treatment. According to the company's website, it extracts adult stem cells exclusively from postnatal placentas.